DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Pituitary masses and visual-field defects

Essential points for quick revision.

Synopsis

Recognise optic chiasm and hormonal consequences of a sellar mass, prioritise cortisol and vision, and sequence MRI, formal perimetry, endocrine classification and specialist treatment safely.

  • A sellar mass may present through visual loss, headache, cranial nerve palsy, hormone excess, pituitary deficiency or incidental imaging; size alone does not establish clinical significance.
  • Upward expansion compresses the optic chiasm classically causing bitemporal field loss, but junctional, asymmetric or central defects occur and patients may not notice gradual peripheral change.
  • New or progressive visual acuity loss, field deterioration, diplopia or reduced consciousness requires urgent pituitary, ophthalmology and neurosurgical assessment rather than routine clinic surveillance.

Key red flags

Thunderclap headache with visual loss, ophthalmoplegia, meningism or altered consciousness suggests pituitary apoplexy and requires immediate emergency management.

Investigation priorities

01
Dedicated contrast pituitary MRIFirst step

Define lesion compartment, optic relationship, cavernous extension, haemorrhage and differential morphology.

Management branches

VISIONNew visual defect with sellar mass

Visual field, acuity, colour or ocular-motor change suggests optic or cavernous compression.

  1. Document bedside acuity, pupils, fields, colour and eye movements, and ask specifically about sudden headache or altered consciousness.
  2. Check haemodynamics, glucose, sodium and urgent cortisol status, giving emergency hydrocortisone if apoplexy or adrenal failure is plausible.

Key medicines

Hydrocortisone for central adrenal insufficiencyUse a physiological divided oral replacement regimen when stable, or immediate parenteral stress dosing when apoplexy, shock or failed absorption is suspected.
CabergolineBegin the pituitary specialist's low weekly regimen with food and titrate against prolactin, visual recovery, tumour size and tolerability.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom